Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate vs midazolam in moderate traumatic brain injury
ChiCTR2100048602Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in traumatic brain injury (TBI) (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Sedative dose, Regional cerebral oxygen saturation and 2 more. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ChiCTR2100048602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048602.